Diagnostics, therapies and cures
Studying pluripotent stem cells will help us understand more about the early stages of embryonic development
To develop new therapies and cures
To understand human health and disease
Will lead to new therapies for muscular dystrophies
Developing therapies for type 2 diabetes
Will define new approaches to treat neurological and cardiovascular disease
The Center for Molecular Medicine’s mission is to better understand the molecular and cellular basis of human disease and to use this information to guide the development of new diagnostics, therapies, and cures.
Research areas include:
Nov 7, 2022 – Bridging Centers Worksop: “Growing Connections”
8:30am-4:30pm
The faculty and research teams of the CCRC, CMM, RBC, and CNDR at UGA will hold a joint Workshop to explore common research interests in neurodegeneration, regeneration, developmental biology, and brain cancer.
Scan the code below or click the link to see the schedule:
Sep 16, 2022–Bi lab received a 2-year NIH/NIAMS R21 award ($415,250) for the project “Discover the Boosters of Myoblast Fusion”. Impact Score 10, Percentile 1%. Congratulations!
Sep 6, 2022–Bi lab received a 5-year NIH/NIGMS R35 award ($1,887,500) for the project “Spatial genetics investigation of multinucleated cells”. Impact Score 22. Congratulations!
Sep 2, 2022–Bi lab published the new story about the evolution of myoblast fusion in “Science Advances“. This work describes an interesting scheme of muscle evolution and has implications for a clear understanding of myoblast fusion. Congratulations!
The Zeltner lab receives an NIH/NICHD R21 award for the project of “Generation of multilineage adrenal gland organoids using human pluripotent stem cells”